SEC Form 4 · accession 0001104659-17-038153
T2 Biosystems, Inc. · TTOO
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
John McDonough
Officer — President and CEO · Director
Period of report
Jun 6, 2017
Accepted (ET)
Jun 8, 2017 · 4:15 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001492674
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 6, 2017 | M | 16,806 | $1.16 | A | 214,159 | D | |
| Common Stock | Jun 6, 2017 | M | 11,729 | $1.16 | A | 225,888 | D | |
| Common Stock | Jun 6, 2017 | M | 21,465 | $1.96 | A | 247,353 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $1.16 | Jun 6, 2017 | M | 16,806 | D | Jul 25, 2012 | Jan 16, 2019 | Common Stock | 16,806 | 0 | D |
| Stock Option (Right to Buy) | $1.16 | Jun 6, 2017 | M | 11,729 | D | Feb 27, 2013 | Feb 27, 2019 | Common Stock | 11,729 | 0 | D |
| Stock Option (Right to Buy) | $1.96 | Jun 6, 2017 | M | 21,465 | D | Jun 24, 2014 | Sep 14, 2020 | Common Stock | 21,465 | 106,025 | D |
Explanation of responses
- F1Includes 12,590 shares acquired under the Issuer's employee stock purchase plan between April 30, 2015 and May 15, 2017.